Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02768155 · ClinicalTrials.gov registry record · NA
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02768155 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 60 participants.
The verdict
NCT02768155, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
A study evaluating Amniotic Fluid compared to a Saline Placebo Injection in the treatment of subjects with osteoarthritic (OA) knee pain
Interventions
- OTHER Placebo Control
- OTHER Amniotic Fluid 4.0ml dose
- OTHER Amniotic Fluid 2.0ml dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02768155
The ClinicalTrials.gov registry entry for NCT02768155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Control is the first listed.
NCT02768155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02768155 about?
NCT02768155 is a clinical study titled "Evaluation of Amniotic Fluid Product in Knee Osteoarthritis". A study evaluating Amniotic Fluid compared to a Saline Placebo Injection in the treatment of subjects with osteoarthritic (OA) knee pain
What is the current status of trial NCT02768155?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02768155?
The interventions under investigation include: Placebo Control (OTHER), Amniotic Fluid 4.0ml dose (OTHER), Amniotic Fluid 2.0ml dose (OTHER).
Who is sponsoring clinical trial NCT02768155?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.